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Tennis - when strict liability is not so strict 
 
Peter Charlish is a lecturer in law at Sheffield Hallam University 
Greg Rusedski, the British No 2 tennis player learned yesterday, (11th March 2004), 
that he would not be facing a two year ban for testing positive for the banned steroid 
nandrolone. Rusedski tested positive in July 2003 with a reading of 5 nanograms per 
millilitre of urine, (the threshold level is two nanograms per millilitre and to give some 
comparison, Linford Christie had a level of 200 nanograms, C.J. Hunter the 
American shot putter 2000 nanograms and Petr Korda, the tennis player 40 
nanograms1, when they were all banned from their respective sports).  
Rusedski argued that the source of his elevated nandrolone levels were salt tablets 
actually distributed by the Association of Tennis Professionals, (ATP), the governing 
body of men’s tennis. His defence rested on the fact that seven other samples from 
players, collected by the ATP had had positive readings and a further 36 had what 
were deemed to be elevated, but not positive levels, (in other words, sufficiently high 
enough to cast doubt, but not enough to convict). However, these samples were 
collected between August 2002 and May 2003, after which time, the tablets were 
withdrawn by the ATP. Rusedski, as already stated tested positive in July, his 
argument being that the ATP had not informed the players personally that the tablets 
had been withdrawn and that therefore he continued to take them, and hence he was 
it seemed an innocent victim of this failure of communication. The verdict, reported in 
the Times2, stated: 
He (Rusedski) argued that it was unfair that the ATP 
should seek to prosecute him for substances which they 
themselves have given to him, which in all probability 
caused him to test positive … they (ATP), could have and 
should have taken steps to notify its players in a 
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 www.timesonline.co.uk 11th March 2004 
‘meaningful’ and ‘direct’ way of its decision to cease 
distributing the electrolyte tablets that it had previously 
handed out so freely. 
 
There are several areas of concern about this particular passage. The Times 
continued3: 
The tribunal, selected by the ATP, rounded on the 
governing body for not having talked to Rusedski about 
its decision to withdraw the salt tablets from distribution in 
May 2003 – although messages were posted on locker 
room walls and printed in the player’s weekly newsletter 
for three months. 
 
It is difficult to see what else the ATP could have done other than communicating 
individually with all its members, (they have over 1400 members). It could certainly 
be argued that they had done all that could reasonably be asked of them and that 
where there is a change in policy all that is required is reasonable consultation or 
reasonable notice, and that the measures taken by the ATP were, or at least should 
have been, sufficient to fulfil their obligations towards their members. 
The second significant strand of Rusedski’s defence lay in the analytical make up of 
his test result. As the Independent newspaper reported, before the hearing4: 
As the issue drags on, so the other competitors on the 
ATP Tour wonder where the situation will lead – 
particularly six of the players who were let off even 
though Rusedski’s sample and theirs demonstrated a 
common analytical fingerprint, (emphasis added) 
 
This factor seems to suggest either that the samples came from the same source, or 
that they were all contaminated in the same way. 
In his defence, Rusedski relied on the fact that the players with whom his sample 
apparently shared the same analytical makeup had not been banned from the sport 
and that therefore he too should be cleared, as there must be doubt about the 
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integrity of either the testing procedure or of the tablets themselves. Further 
investigations have uncovered no tablet contamination and therefore the suspicion 
must be that it is the testing process that has allowed this contamination. Rusedski’s 
defence was bolstered by the admittance of the ATP that in the case of at least one 
of the player’s with whom Rusedski’s sample shared common characteristics, 
(Bohdan Ulihrach), it was likely that his positive test was caused by substances 
given to him by the ATP, therefore by associating himself with Ulihrach in the 
manner described, the British tennis star was able to cast sufficient doubt upon the 
integrity of his own test result.  
This is undoubtedly a huge issue not just for tennis, but for the worldwide battle 
against doping in sport. In the time between Rusedski’s public unmasking and his 
acquittal, sixteen more tennis players have been found to have elevated levels of 
nandorlone in their urine5.  
There has been much concern about the implications for sport of the Rusedski 
decision. The World Anti Doping Agency, (WADA), issued a statement in the wake 
of the decision. It stated6: 
The decision only exacerbates the Wada’s concerns 
regarding the initial decision taken by the tribunals in the 
seven previous cases. As we have stated in the past, 
the decision to exonerate was based on a scientific 
theory regarding the electrolytes and is not 
conclusive. The fact that another case has now been 
adjudicated based on the same premise is greatly 
disturbing, particularly if it is proved to be incorrect. 
(emphasis added) 
 
The ATP has, as is common with nearly all other sports, its own anti doping 
program. The stated purpose of this program is7: 
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 ATP Tennis Anti-Doping Program 2004, Article A (1) 
The purpose of this Tennis Anti-Doping Program (the 
“Program”) is to maintain the integrity of tennis and to 
protect the health and rights of all tennis players. 
 
The regulations are quite specific on the issue of prohibited substances being found 
within the body of any participant. Article C(1)(a) states8: 
It is each Player’s duty to ensure that no Prohibited 
Substance enters his body. A Player is responsible for 
any Prohibited Substance or its Metabolites or 
Markers found to be present in his Specimen. 
Accordingly, it is not necessary that intent, fault, 
negligence or knowing Use on the Player’s part be 
demonstrated in order to establish a Doping Offense 
under Article C.1; nor is the Player’s lack of intent, fault, 
negligence or knowledge a defence to a charge that a 
Doping Offense has been committed under Article C.19 
 
An exception to the severity of this rule is if the prohibited substance can be 
produced internally, by the body, (Article C.1(c)). There is a possible defence if the 
substance in question is for therapeutic use. However, in order to qualify for this 
exemption, the player in question must have obtained a “therapeutic use exemption”, 
before ingesting the substance10. Quite clearly, this does not apply to Rusedski, 
although it is reasonable to assume that he would try and link the fact that the tablets 
were provided by the ATP themselves, as sufficient to at least suppose that this may 
be classified as therapeutic use. 
It falls to the ATP to establish that a doping Offence has taken place, and that further 
more11: 
The standard of proof shall be whether the ATP has 
established the commission of the alleged Doping 
Offense to the comfortable satisfaction of the Anti-
Doping Tribunal, bearing in mind the seriousness of the 
allegation that is made. This standard of proof in all 
cases is greater than a mere balance of probability but 
less than proof beyond reasonable doubt. 
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 ATP Tennis Anti-Doping Program 2004, Article K(3) 
 This is an offence of strict liability, with narrow stated exceptions, the very presence 
of the banned substance sufficient without more of being in violation of the anti-
doping regulations promulgated by the ATP. Article 3(1) states12: 
The presence of a Prohibited Substance or its 
Metabolites or Markers in a Player’s Specimen, unless 
the Player establishes the presence is pursuant to a 
therapeutic use exemption granted in accordance with 
Article E. 
 
Under these stated regulations, Rusedski was fortunate indeed to be completely 
exonerated. There is no allowance made for how the substance entered the body. If 
it is there, and no exception applies, then the player is guilty. This is the essence of 
strict liability.  
The sanctions for a positive test result are quite clear, first offence being a two year 
ban and any subsequent offence carrying a lifetime ban. There is no apparent 
moderation of this sanction unless a player can establish that the substance was a 
“specified substance”, as defined under Article M(3), which states13: 
The Prohibited List may identify specified substances 
that are particularly susceptible to unintentional anti-
doping rules violations because of their general 
availability in medicinal products or that are less likely to 
be successfully abused as doping agents. … Where a 
Player can establish that the Use of such a Specified 
Substance was not intended to enhance sport 
performance, the period of ineligibility found in Article 
M.2 shall be replaced. 
 
Rusedski’s situation clearly does not fall into this particular exception, as a finite list 
of these “specified substances” is found in Appendix 314. 
Therefore what needs to be asked is what the justification was for sidelining the 
principle of strict liability, in favour of what would appear to be a humanitarian, 
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forgiving and arguably a moral decision. As already stated, it was accepted that 
there was the possibility that Bohdan Ulihrach’s positive test was caused by his use 
of salt tablets supplied by the ATP, and the fact that Rusedski’s sample had the 
same analytical fingerprint as Ulirach’s suggested two possible explanations: Either 
that they ingested the same apparently contaminated ATP supplied tablets, or there 
was contamination of their samples emanating from the testing procedure. The fact 
that in this year alone a further 16 players have tested positive for the same banned 
drug seems to suggest that something is fundamentally wrong with the testing 
procedures of the ATP, or that systematic drug abuse is rife in men’s tennis. It is 
interesting to note that this profusion of positive test results have not occurred at the 
Grand Slam events15, which are administered by a separate organisation16, but only 
at events administered by the ATP.  
There is of course a further possible explanation that clearly was not accepted by 
the panel; that both players were guilty of ingesting the same banned substance, 
obtained from another source. As reported in The Guardian newspaper17: 
Yesterday’s developments indicate that the pills are 
either still in circulation or that they were never the 
source. Last night the ATP admitted that it was no closer 
to a definitive answer. 
 
Whatever the explanation, the stated regulations of the ATP are that the player, if 
found with a banned substance in their body, should face an automatic ban. So why 
were these rules not followed? 
The stated reasons are that the ATP failed to adequately warn their players of the 
possibility of the supplied tablets being contaminated and that once this was 
discovered and they were withdrawn, then the ATP had a responsibility to take all 
                                            
15
 The Australian Open, The French Open, Wimbledon and the US Open 
16
 International Tennis Federation 
17
 Stephen Bierley & Paul Kelso, The Guardian, March 11th 2004, p1 
possible means to inform and educate their members as to this risk. The tribunal 
actually stated18: 
The ATP could have – and should have – taken steps to 
notify its players in a ‘meaningful’ and ‘direct’ way of the 
reasons for its decision to cease distributing the 
electrolyte tablets that it had previously handed out so 
freely. 
 
As already stated, it is difficult to see what else the ATP could have done, other than 
directly contacting each and every one of the members of the ATP. It is suggested 
that their action in withdrawing the tablets, putting notices up in the player locker 
rooms and posting messages in the weekly player newsletter, was reasonable in the 
circumstances. 
The possible source of Mr Ulihrach’s positive test, which was accepted by the ATP, 
was the possibly contaminated salt tablets. The implication, due to circumstances 
was that therefore Rusedski’s sample could have been contaminated in the same 
fashion. However, concerning these tablets, the Times reports19: 
The ATP was able to identify only one jar which 
appeared to have been used at a tournament where 
positive or elevated tests occurred. All of the 
approximately 500 tablets in the remaining half of the jar 
were analysed at an IOC20 laboratory in Cologne. No 
contamination was found. (emphasis added) 
 
It is unfortunate that no contaminated tablets have been found, however, the 
question of the existence or otherwise of these contaminated tablets should not have 
ever arisen. Based on the applicable principle of strict liability, once illegal 
substances have been found in a urine sample, then the individual should be found 
guilty, however the illegal substances got into the person’s body in the first place.  
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 International Olympic Committee 
The World Anti Doping Agency, (WADA), in the wake of the Rusedski decision 
expressed its concern. David Howman, WADA director-general, stated21: 
We have been concerned about all of these nandrolone 
cases in tennis in two aspects; one because there is the 
erosion of strict liability (the regulation by which 
competitors are always responsible for what they 
consume) and also because of the large number of 
nandrolone findings in tennis. 
 
There can be no justification for this erosion of the principle of strict liability. It is 
pointless having such a standard available if at the first sight of an unjust outcome, 
the principle is disregarded.  
The rationale for a policy of strict liability is a laudable attempt to level the playing 
field in competitive sports, and it is certain that at times, unjust results will occur. 
However, what is without doubt is that the policy was implemented for very specific 
reasons, aptly summed up in the decision from the Court of Arbitration for Sport in 
Quigley v UIT22: 
It is true that a strict liability test is likely in some sense to 
be unfair in an individual case … where the Athlete may 
have taken medication as the result of mislabelling or 
faulty advice for which he or she is not responsible. … 
But it is also in some sense ‘unfair’ for an Athlete to get 
food poisoning on the eve of an important competition. 
Yet in neither case will the rules of the competition be 
altered to undo the unfairness. Just as the competition 
will not be postponed to await the Athlete’s recovery, so 
the prohibited banned substance will not be lifted in 
recognition of its accidental absorption. The vicissitudes 
of competition, like those of life generally may create 
many types of unfairness, whether by accident or the 
negligence of unaccountable Persons, which the law 
cannot repair. 
Furthermore, it appears to be a laudable policy objective 
not to repair an accidental unfairness to an individual by 
creating an intentional unfairness to the whole body of 
other competitors. This is what would happen if banned 
performance enhancing substances were tolerated when 
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absorbed inadvertently. Moreover it is likely that even 
intentional abuse would in many cases escape sanction 
for lack of proof of guilty intent. And it is certain that a 
requirement of intent would invite costly litigation that 
may well cripple federations. 
 
The decision to completely exonerate Greg Rusedski is without doubt a humane 
decision, which will be welcomed by his legion of fans. It seemed to be based on the 
principle that it would have been unfair of the ATP to ban Rusedski for taking, in 
good faith, substances provided by the ATP. In more legal terms, the stated reason 
was based on the principle of estoppel, which23: 
prevents a person from adopting a position inconsistent 
with an earlier position if it results in injury to someone 
else. 
 
However, what this decision has done is add an unnecessary layer of uncertainty to 
an already difficult area. There must be clarity when dealing with this issue, and the 
principle of strict liability brought such clarity. The decision of the tribunal, in 
disregarding the principle of strict liability, and erring on the side of morality and 
justice rather than clarity and certainty may well have been a satisfactory result for 
Greg Rusedski, but it is one which individuals such as Dwain Chambers24 will look 
upon with a certain amount of anger. Tennis has, by this verdict, left itself open to 
charges of incompetence at best or cover-up and corruption at worst. It is a course 
of action that they may come to regret. 
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